There is a newer version
of
this Article
2020 North Carolina General Statutes
Chapter 90 - Medicine and Allied Occupations
Article 23A - Right to Try Act.
- § 90-325 - Short title; purpose.
- § 90-325.1 - Definitions.
- § 90-325.2 - Authorized access to and use of investigational drugs, biological products, and devices.
- § 90-325.3 - No liability to heirs for outstanding debt related to use of investigational drugs, biological products, or devices.
- § 90-325.4 - Sanctions against health care providers prohibited.
- § 90-325.5 - Prohibited conduct by State officials.
- § 90-325.6 - No private right of action against manufacturers of investigational drugs, biological products, or devices.
- § 90-325.7 - Insurance coverage of clinical trials.
- § 90-325.8 - Reserved for future codification purposes.
- § 90-325.9 - Reserved for future codification purposes.
- § 90-325.10 - Reserved for future codification purposes.
- § 90-325.11 - Reserved for future codification purposes.
- § 90-325.12 - Reserved for future codification purposes.
- § 90-325.13 - Reserved for future codification purposes.
- § 90-325.14 - Reserved for future codification purposes.
- § 90-325.15 - Purpose.
- § 90-325.16 - Definitions.
- § 90-325.17 - Authorized treatments.
- § 90-325.18 - Institutional review boards; annual report; rules.
- § 90-325.19 - Prohibited purchase and sale of adult stem cells for certain investigational treatments.
- § 90-325.20 - Sanctions against physicians prohibited.
- § 90-325.21 - Prohibited conduct by government officials.
- § 90-325.22 - Insurance of clinical trials.
Disclaimer: These codes may not be the most recent version. North Carolina may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.